Asia looms as new gold haven
These forward-looking ASX-listed resource juniors are proving that their Asian gold resources that have the hallmarks of significant plays.
Stockhead
Predator and Prey: Asra Minerals
Predator and Prey analyses emerging explorers and why they might attract acquisition interest. This time we’re looking at Asra Minerals.
ASX biotechs take on traumatic brain injury
Advocates of TBI awareness are pushing for better care while ASX companies drop devices and drugs that are stepping up the fight.
ASX up 1.2pc as tech shines, jobs dip
ASX rises +1pc, Nanosonics jumps after FDA approval, and Aussie job numbers dip, sparking rate cut hopes.
More Stories
Almonty strong on tungsten deal
Almonty Industries has continued its strong recent run, securing a partnership deal for tungsten concentrate with American Defense International.
ASX snaps win streak, eyes now on Fed’s move
ASX gets smacked by Wall Street sell-off, MinRes tumbles after haul road drama, and all eyes are now on the Fed’s next move.
AZL eyes $2m raise for Prairie lithium
Arizona Lithium is launching a $2m share purchase plan to advance its Prairie lithium project towards phase 1 production.
Road to 2025: Comet Ridge
Tylah Tully looks at Comet Ridge’s achievements in 2024, and big plans for 2025 at its Mahalo Gas Hub projects.
PTR drills for more titanium at Muckanippie
Petratherm has kicked off its second phase of drilling at the Muckanippie titanium-rich heavy mineral sands project in South Australia.
Gold opportunities abound for Arika at Yundamindra
Arika Resources is ramping up exploration at the Yundamindra gold project after a historic review of surface samples revealed 27 new targets.
Prospect gets Phase 2 drill planning underway
Fieldwork is continuing to deliver impressive results in the lead up to Phase 2 drilling at the Mumbezhi copper project in Zambia.
ASX rocky, MinRes tumbles 7pc after mis
The ASX has taken a hit as Wall Street’s nerves spread. Meanwhile the Fed is likely to keep things steady, and MinRes and Wisetech face a rough day.
StockTake: Axel REE
Axel REE has made encouraging progress at its Caladão project in Brazil, reconfirming its gallium and rare earth potential.
Break it Down: EmVision Medical Devices
EMVision’s completed further testing of its proof-of-concept First Responder device for traumatic brain and stroke injuries.
Original URL: https://www.thechronicle.com.au/business/stockhead/page/4